Deluph Global Enterprise Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Deluph Global Enterprise Pharmaceutical Import Records from India — 2 Products, $62.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Deluph Global Enterprise — Pharmaceutical Importer Profile (2026) | 2 Products, $62.9K Trade | TransData Nexus

Deluph Global Enterprise

Pharmaceutical Importer · Nigeria · Antimalarial & Antiparasitic Focus · $62.9K Total Trade · DGFT Verified

Deluph Global Enterprise is a pharmaceutical importer based in Nigeria with a total trade value of $62.9K across 2 products in 1 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Deluph Global Enterprise sources from 1 verified Indian supplier, with Centurion Remedies Private Limited accounting for 100.0% of imports.

Deluph Global Enterprise — Import Portfolio & Supplier Network

Deluph Global Enterprise import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Deluph Global Enterprise?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Centurion Remedies Private Limited	$31.4K	2	100.0%

Deluph Global Enterprise sources from 1 verified Indian supplier across 1 distinct formulations. The sourcing is highly concentrated — Centurion Remedies Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Deluph Global Enterprise Import?

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Praziquantel	Antimalarial & Antiparasitic	$31.4K	2	1.1%	12
2	Pyrantel	Antimalarial & Antiparasitic	$31.4K	2	1.0%	17

Deluph Global Enterprise imports 2 pharmaceutical products across 1 categories into Nigeria totaling $62.9K.

Deluph Global Enterprise — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Deluph Global Enterprise is a Nigerian pharmaceutical importer and buyer specializing in the acquisition of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is headquartered at 23 Ekololu Street, Surulere, Lagos, Nigeria. Established on 13 September 2019, Deluph Global Enterprise operates as a partnership, with Mrs. Ugochi serving as the Director. The company's primary role in Nigeria's pharmaceutical distribution network is to source and import pharmaceutical products, ensuring their availability within the domestic market.

2Distribution Network

Deluph Global Enterprise's distribution network is centered in Lagos, Nigeria, with its main office located at 23 Ekololu Street, Surulere. While specific details regarding warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities suggest a focus on efficient supply chain management to facilitate the timely delivery of pharmaceutical products. The geographic coverage appears to be primarily within Nigeria, serving the domestic market's pharmaceutical needs.

3Industry Role

In Nigeria's pharmaceutical supply chain, Deluph Global Enterprise functions as a pharmaceutical importer and buyer. The company sources finished pharmaceutical formulations from international suppliers, particularly from India, and imports them into Nigeria. By doing so, Deluph Global Enterprise plays a crucial role in ensuring the availability of essential medications within the Nigerian market, thereby contributing to the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Deluph Global Enterprise

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Deluph Global Enterprise demonstrates a high level of supplier concentration, with a total import value of $63,000 USD from India across four shipments. Notably, CENTURION REMEDIES PRIVATE LIMITED is the sole verified Indian supplier, accounting for the entire import value. This single-source dependency may pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent sourcing from a single supplier could also indicate a strategic choice aimed at maintaining product consistency and quality. The shipment data reveals a stable relationship with CENTURION REMEDIES PRIVATE LIMITED, as evidenced by the two shipments recorded in 2024, each valued at $18,850 USD.

2Supply Chain Resilience

The resilience of Deluph Global Enterprise's Indian supply chain appears to be moderate. The company's reliance on a single supplier, CENTURION REMEDIES PRIVATE LIMITED, suggests limited diversification, which could impact the supply chain's robustness in the event of disruptions. There is no publicly available information regarding backup suppliers or the diversity of formulations imported. Additionally, specific details about shipping route exposure and the regulatory compliance of key suppliers are not disclosed, making it challenging to fully assess the supply chain's resilience.

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) is the primary regulatory authority overseeing the importation, distribution, and manufacturing of pharmaceutical products. NAFDAC's mandate includes ensuring that all drugs imported into Nigeria are safe, effective, and of good quality. The regulatory framework governing pharmaceutical imports is outlined in the NAFDAC Act CAP N1 (LFN) 2004, which stipulates that no drug shall be manufactured, imported, exported, advertised, sold, distributed, or used in Nigeria unless it has been registered in accordance with the provisions of the Act and other related legislations. (nafdac.gov.ng)

2Import Licensing & GMP

Import licensing requirements in Nigeria mandate that all pharmaceutical products imported into the country must be registered with NAFDAC. This process involves submitting a comprehensive application that includes a Certificate of Analysis for each batch, a valid Certificate of Manufacture from the country of origin, and evidence of Good Manufacturing Practice (GMP) compliance. NAFDAC recognizes GMP certificates from various international standards, including EU GMP, WHO GMP, and PIC/S. Additionally, importers must obtain a valid Import Permit stating the quantities of the products to be imported. (nafdac.gov.ng)

Deluph Global Enterprise — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Deluph Global Enterprise's focus on importing antimalarial and antiparasitic medications, specifically Praziquantel and Pyrantel, indicates a strategic alignment with addressing prevalent health concerns in Nigeria. Both therapeutic areas are critical in the Nigerian context, given the high incidence of parasitic infections such as schistosomiasis and soil-transmitted helminthiasis. The market demand for these medications is driven by the need for effective treatments to combat these widespread diseases, highlighting the company's role in fulfilling a significant public health need.

2Sourcing Profile

Deluph Global Enterprise's sourcing strategy is centered on importing generic drug formulations from India, focusing on specific therapeutic areas such as antimalarial and antiparasitic medications. The company's preference for finished pharmaceutical formulations suggests a streamlined procurement process aimed at ensuring product availability and quality. India's established pharmaceutical manufacturing capabilities and adherence to international quality standards make it a suitable partner for Deluph Global Enterprise's procurement needs.

3Market Positioning

Seller's Guide — How to Become a Supplier to Deluph Global Enterprise

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Deluph Global Enterprise, particularly in the antimalarial and antiparasitic therapeutic categories. The company's current sourcing pattern, characterized by a high concentration on a single supplier, presents an opportunity for diversification. Indian exporters can explore this potential by offering competitive pricing, reliable delivery schedules, and adherence to international quality standards. Building a relationship with Deluph Global Enterprise could lead to a mutually beneficial partnership, enhancing the company's product offerings and market reach.

2Requirements & Qualifications

Indian exporters seeking to supply Deluph Global Enterprise and the Nigerian market must ensure that their pharmaceutical products are registered with NAFDAC. This involves submitting a comprehensive application that includes a Certificate of Analysis for each batch, a valid Certificate of Manufacture from the country of origin, and evidence of Good Manufacturing Practice (GMP) compliance. NAFDAC recognizes GMP certificates from various international standards, including EU GMP, WHO GMP, and PIC/S. Additionally, importers must obtain a valid Import Permit stating the quantities of the products to be imported. (nafdac.gov.ng)

Frequently Asked Questions — Deluph Global Enterprise

What products does Deluph Global Enterprise import from India?

Deluph Global Enterprise imports 2 pharmaceutical products across 1 categories. Top imports: Praziquantel ($31.4K), Pyrantel ($31.4K).

Who supplies pharmaceuticals to Deluph Global Enterprise from India?

Deluph Global Enterprise sources from 1 verified Indian suppliers. The primary supplier is Centurion Remedies Private Limited (100.0% of imports, $31.4K).

What is Deluph Global Enterprise's total pharmaceutical import value?

Deluph Global Enterprise's total pharmaceutical import value from India is $62.9K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Deluph Global Enterprise focus on?

Deluph Global Enterprise imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Deluph Global Enterprise Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.